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Abstract
Background: Nosocomial candidaemia is associated with high mortality rates in critically ill paediatric patients; thus,
the early detection and identification of the infectious agent is crucial for successful medical intervention. The
PCR-based techniques have significantly increased the detection of Candida species in bloodstream infections.
In this study, a multiplex nested PCR approach was developed for candidaemia detection in neonatal and paediatric
intensive care patients.
Methods: DNA samples from the blood of 54 neonates and children hospitalised in intensive care units with
suspected candidaemia were evaluated by multiplex nested PCR with specific primers designed to identify seven
Candida species, and the results were compared with those obtained from blood cultures.
Results: The multiplex nested PCR had a detection limit of four Candida genomes/mL of blood for all Candida
species. Blood cultures were positive in 14.8% of patients, whereas the multiplex nested PCR was positive in 24.0%
of patients, including all culture-positive patients. The results obtained with the molecular technique were available
within 24 hours, and the assay was able to identify Candida species with 100% of concordance with blood cultures.
Additionally, the multiplex nested PCR detected dual candidaemia in three patients.
Conclusions: Our proposed PCR method may represent an effective tool for the detection and identification of
Candida species in the context of candidaemia diagnosis in children, showing highly sensitive detection and the
ability to identify the major species involved in this infection.
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Background
Candida is the main etiological agent of nosocomial op-
portunistic mycoses worldwide and is associated with
high mortality rates, especially in patients with under-
lying diseases [1,2]. Candida species are the third most
common pathogen isolated from bloodstream infections
of preterm infants and the fourth most common patho-
gen in paediatric intensive care unit (ICU) patients [3-5].
The incidence of invasive candidiasis among critically ill
paediatric patients has increased during the last two de-
cades, and the outcome of Candida infections is particu-
larly poor in very low birth weight infants due to central
nervous system involvement, leading to neurodevelop-
mental impairment [6].
Candida albicans is the most frequent cause of candi-
daemia in paediatric patients, followed by C. parapsilosis
in neonates. Candida tropicalis has been frequently re-
ported in bloodstream infections of neonates and chil-
dren in Latin America and some regions of southern
Asia [7,8].
Some groups of paediatric patients are especially pre-
disposed to candidaemia, including preterm infants, chil-
dren with haematological malignancies, stem cell and
solid organ transplant recipients, children requiring a
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prolonged hospital stay in the ICU, and children under-
going medium or large surgeries. There are also risk fac-
tors associated with candidaemia, such as the use of
central venous or arterial catheters, broad-spectrum an-
tibiotics, and parenteral nutrition [3,5].
The gold standard of laboratory diagnosis remains the
isolation of Candida species by blood culture. However,
the sensitivity of blood cultures is approximately 50%,
and the collection of small blood volumes in neonates
and young children further decreases this sensitivity [9].
In addition, a time period of 48 to 96 hours is required
for the identification of Candida species by blood cul-
ture [10]; thus, faster detection of Candida spp. in the
blood would expedite the initiation of treatment, im-
proving the prognosis of patients [11]. In an attempt to
shorten the time required for detection of candidaemia,
several groups have developed non-culture methods
based on the polymerase chain reaction (PCR), which
has proved to be highly sensitive and specific for the de-
tection of Candida DNA in the blood samples of at-risk
patients [12,13]. In addition, multiplex PCR designed to
detect different targets simultaneously is time-saving
and more cost-effective than the standard PCR [10,14].
This study aimed to develop a multiplex nested PCR
method to detect and identify seven Candida species in
peripheral blood samples of critically ill paediatric pa-
tients presenting with predisposing conditions/risk fac-
tors for the development of candidaemia. The results of
PCR were compared with those of blood cultures.
Methods
Patients and blood samples
This research was approved by the human research eth-
ics committee of our institutions [Comissão de Ética
para Análise de Projetos de Pesquisa do Hospital das
Clínicas da FMUSP, São Paulo, SP, Brazil and Comitê de
Ética em Pesquisa da FAMERP, São José do Rio Preto, SP,
Brazil].
This prospective study enrolled 54 consecutive paedi-
atric patients, among whom there were 24 neonates, ad-
mitted to the ICU of two paediatric referral hospitals in
São Paulo State, Brazil. The patients presented with sys-
temic inflammatory response syndrome (SIRS) according
to the International Pediatric Sepsis Consensus [15] and
at least two predisposing conditions/risk factors for the
development of candidaemia.
The control group included 28 children from the
Pediatric Surgery Division of the Instituto da Criança –
HCFMUSP that had no evidence of any type of blood-
stream infection and had undergone minor surgical
procedures during the same time. The number of stud-
ied cases and controls was determined based on the 18-
month period set for the completion of the research
(convenience sample).
Although all the patients had central catheters, blood
samples for use in cultures and multiplex nested PCR
were collected from a peripheral vein after written con-
sent was obtained from parents or legal guardians.
Blood cultures and phenotypic identification of
Candida isolates
Cultures were obtained aseptically by inoculating 1-2 mL
of blood samples into Bactec Peds Plus/F bottles (Becton
Dickinson, Franklin Lakes, NJ, USA), which were incu-
bated in a Bactec™ 9240 analyser (Becton Dickinson). The
organisms obtained from positive cultures were identified
using the Vitek®2 system (BioMérieux, Marcy-l’Etoile,
France). Blood cultures were not performed for mem-
bers of the control group due to the absence of a clinical
indication for this exam.
DNA extractions and PCR to amplify the β-actin gene
DNA extractions were performed according to the tech-
niques described by Löeffler et al. [16] with modifications.
Briefly, 10 mL of blood lysis solution was added to 1-2 mL
of blood sample, and the mixture was centrifuged for
15 minutes at 2190 × g. Nucleo lysis solution (1 mL) was
added to the cell pellet, and the solutions were homoge-
nised. Recombinant lyticase (L-2524, Sigma-Aldrich, St.
Louis, MO, USA) at 250 U/mL and 2% β-mercaptoethanol
(Merck, Darmstadt, Germany) were added, and the tubes
were maintained at 37°C for 2 hours. The tubes were then
centrifuged for 20 minutes at 15,300 × g and the super-
natant was transferred to clean tubes. The remaining steps
were performed with the QIAamp DNA mini kit (QIA-
GEN, Hilden, Germany) according to the manufacturer’s
instructions. Then, the 54 DNA samples were amplified
using a pair of human β-actin gene primers to ensure the
integrity of the DNA and the absence of amplification
inhibitors.
Candida prototype strains
DNA was extracted from seven Candida prototype strains
(C. albicans ATCC18804, C. glabrata ATCC2001, C. para-
psilosis ATCC22019, C. tropicalis ATCC 200956, C. krusei
ATCC6258, C. lusitaniae ATCC66035, and C. pelliculosa
ATCC8168) using a previously described method [17], and
these samples were used as positive controls.
PCR primers
The fungus-specific universal oligonucleotides ITS1 and
ITS4 [18] were used as outer primers. In the second ampli-
fication, the previously described inner primers for C. albi-
cans, C. glabrata, C. parapsilosis complex, C. tropicalis, and
C. krusei were used [18,19]. The primers for C. lusitaniae
and C. pelliculosa were designed with the PrimerQuestSM
and Primer-BLAST tools. The primer sequences are listed
in Table 1.
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Multiplex nested PCR and detection of amplification
products
To avoid carryover contamination of the assays, reaction
mixes, DNA extractions and amplifications were set up
in separate rooms equipped with safety cabinets [20].
The first round of amplification was carried out in a
25 μL reaction mixture containing 1× PCR buffer (Invi-
trogen, Carlsbad, CA, USA), 200 μM dNTP (GE Health-
care, Buckinghamshire, UK), 1.5 mM MgCl2, 0.2 μM
each primer (ITS1 and ITS4), 1.25 U Platinum Taq DNA
polymerase (Invitrogen), and 50 ng of genomic DNA
from blood samples, which served as the DNA template.
The PCR cycling conditions were as follows: an initial
denaturation step of 5 min at 95°C followed by 35 cycles
of 45 s at 95°C, 45 s at 50°C, and 45 s at 72°C, with a
final extension of 5 min at 72°C. The reactions were car-
ried out in a Veriti thermocycler (Applied Biosystems,
Carlsbad, CA, USA).
The second round of amplifications were performed in
two separate assays: assay 1, containing primers CLU,
CTR, CALB, and CGL at concentrations of 0.1 μM,
0.12 μM, 0.2 μM, and 0.3 μM, respectively; and assay 2,
containing primers CKR, CPAR, and CPEL at concentra-
tions of 0.2 μM, 0.15 μM, and 0.12 μM, respectively. In
both assays, 2 μL of a 1:100 dilution of the ITS PCR prod-
uct was used as the DNA template. This template was
mixed with the inner primers and 5% dimethyl sulfoxide
(Merck, Darmstadt, Germany) to fresh reaction mixtures
in a total volume of 25 μL. The amplifications were carried
out in the same thermocycler under the following condi-
tions: an initial denaturation step of 5 min at 95°C, 10 cy-
cles of 45 s at 95°C, 45 s at 67-58°C (touchdown), and 45 s
at 72°C followed by 20 cycles of 45 s at 95°C, 45 s at 58°C,
and 45 s at 72°C, with a final extension of 5 min at 72°C.
In all experiments, negative controls containing sterile
water instead of genomic DNA and positive controls
containing Candida DNA were tested.
The nested PCR products were detected on 2.5% agar-
ose gels stained with GelRed™ (Biotium, Hayward, CA,
USA) and visualised under a UV transilluminator appar-
atus (UVITEC, Cambridge, UK).
Multiplex nested PCR detection limit and specificity
To determine the detection limit for Candida DNA in
clinical specimens, nested amplifications were performed
with genomic DNA extracted from 1 mL of a blood sample
obtained from a healthy subject spiked with the seven Can-
dida species DNA ranging from 1.5 ng to 15 fg (one Can-
dida genome corresponds to approximately 37 fg of DNA).
Each of the Candida species was tested separately [21].
The PCR specificity was evaluated by testing DNA sam-
ples from microorganisms that are common etiologic
agents of neonatal and paediatric sepsis, such as Staphylo-
coccus aureus, S. epidermidis, Streptococcus pyogenes,
Escherichia coli, Enterococcus faecalis, and Pseudomonas
aeruginosa. The DNA samples of other Candida species
such as C. guilliermondii, C. kefyr, C. famata, C. dublinien-
sis and C. haemulonii, as well as some non-Candida fungi
Table 1 Primers employed in the nested multiplex PCR amplifications
Primers Sequences (5’→ 3’) Amplicons References
ITS 1/4 F- TCCGTAGGTGAACCTGCGG Variable [18]
R- TCCTCCGCTTATTGATATGC
CALB 1/2 F- TTTATCAACTTGTCACACCAGA 272 bp [18]
R- ATCCCGCCTTACCACTACCG
CGL 1/2 F- TTATCACACGACTCGACACT 423 bp [18]
R- CCCACATACTGATATGGCCTACAA
CTR 1/2 F- CAATCCTACCGCCAGAGGTTAT 357 bp [18]
R- TGGCCACTAGCAAAATAAGCGT
CPAR 3/2 F- GCCAGAGATTAAACTCAACCAA 297 bp [18]
R- CCTATCCATTAGTTTATACTCCGC
CKR 2/3 F- ACTACACTGCGTGAGCGGAA 362 bp [19]
R- ACTACACTGCGTGAGCGGAA
CLU 1/2 F- GCGATACGTAGTATGACTTGCAG 137 bp *
R- GATATTTCGGAGCAACGCCTAACC
CPEL 1/2 F-GAACTTTGCTTTGGGTGGTGAG 160 bp *
R- CTTCATCGTTGCGAGAACCAAG
F = forward; R = reverse; CALB = C. albicans; CGL = C. glabrata; CTR = C. tropicalis; CPAR = C. parapsilosis complex; CKR = C. krusei; CLU = C. lusitaniae;
CPEL = C. pelliculosa.
* = primers designed in the current study; bp = base pairs.
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(Cryptococcus sp., Trichosporon sp., Rhodotorula sp., As-
pergillus sp., and Fusarium sp.) were also tested.
Sequencing of the PCR products
To certify that the amplified products corresponded to
Candida sequences, the PCR products generated from
the blood samples that yielded negative blood cultures
were sequenced on an ABI 3730 DNA apparatus (Ap-
plied Biosystems). Sequence alignments were performed
with ClustalW2, and the nucleotide sequence consensus
was compared with those of other Candida strains avail-
able in GenBank using the BLAST tool.
Statistical analysis
Statistical analysis of the results was carried out with
SPSS software (13.0). The McNemar test was employed.
Results
The detection limit of the multiplex nested PCR for the
seven tested Candida species was 150 fg, or the equiva-
lent of four Candida genomes/mL of blood. Regarding
the specificity, the bacteria, other Candida species and
non-Candida fungi did not produce any amplification
products.
Among the 54 enrolled patients, 32 were males and 22
were females, with ages ranging from six days to 16 years.
All patients had central venous catheters and had received
broad-spectrum antibiotics for more than 96 hours at the
time of blood sampling. Subsequently to the blood collec-
tions, 38 patients (70.4%) initiated presumptive antifungal
therapy due to the suspicion of fungal infection.
Blood from eight patients yielded positive cultures
(14.8%), while Candida DNA was detected in 13 patients
(24.0%) by the molecular assay, including the eight pa-
tients with positive cultures (Figure 1). Demographic
data, clinical conditions, and the outcomes of these 13
patients are described in Table 2. The McNemar test did
not uncover a disagreement between the blood cultures
and the multiplex nested PCR results (p = 0.063).
Regarding Candida species identification, PCR was
100% concordant with blood cultures. There were five pa-
tients in whom the multiplex-nested PCR was positive and
the blood cultures were negative. The amplification prod-
ucts were submitted to sequencing analysis and showed 99
to 100% sequence identity with the Candida reference
strains (Table 2). Among these five patients, PCR was able
to identify dual candidaemia (C. parapsilosis sensu stricto
and C. tropicalis) in the blood samples of three patients
with negative cultures (Table 2).
The multiplex nested PCR was consistently negative
when DNA samples obtained from the control group pa-
tients were amplified. In addition, the technique allowed
the release of results in 24 hours, as opposed to the
mean time of 72 hours for blood cultures.
Discussion and conclusions
This study describes the development of a multiplex
nested PCR method to detect and identify the seven of the
most Candida species causing invasive candidiasis in
the paediatric ICU setting: C. albicans, C. parapsilosis,
C. tropicalis, C. glabrata, C. krusei C. lusitaniae and C.
pelliculosa [22,23]. The primers designed to amplify
these Candida species showed consistent and specific
results (Figure 1).
Although C. lusitaniae is less frequently isolated from
paediatric bloodstream infections, the clinical relevance of
the identification of this species relates to its association
with resistance to amphotericin B and worse clinical out-
come [24]. Outbreaks of C. pelliculosa in paediatric inten-
sive care units have already been reported in Brazil [25],
reinforcing the importance of the inclusion of this Can-
dida species in molecular investigations.
This multiplex nested PCR method reached the detec-
tion limit of four Candida genomes/mL of blood for the
Figure 1 Agarose gel showing the nested multiplex PCR products
obtained from patients after amplification with primers for assays
1 and 2. Lane L – 100 bp molecular weight marker (GE Healthcare);
Lanes 1 and 8 – Negative controls; Lanes 2 and 9 – Patient 2
(C. albicans); Lanes 3 and 10 – Patient 8 (C. albicans); Lanes 4 and 11 –
Patient 11 (C. tropicalis); Lanes 5 and 12 – Patient 13 (C. tropicalis and
C. parapsilosis); Lanes 6 and 13 – Patient 7 (C. krusei); Lane 7 – Positive
controls for assay 1: DNA from C. glabrata (423 bp), C. tropicalis (357 bp),
C. albicans (272 bp) and C. lusitaniae (137 bp) reference strains; Lane
14 – Positive controls for assay 2: DNA from C. krusei (362 bp),
C. parapsilosis (297 bp) and C. pelliculosa (160 bp) reference strains.
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seven investigated species, which is an excellent analyt-
ical sensitivity considering the recommendation for can-
didaemia diagnostic molecular tests (i.e., detection of at
least 10 CFU/mL of blood) [2,26]. Tirodker et al. also
compared PCR and blood cultures for Candida detec-
tion in patients in the paediatric ICU with suspected
fungemia, revealing that the molecular technique had a
higher positivity. However, the single-round PCR utilised
by these authors could not discriminate Candida species
and had a detection limit of 100 CFU/0.5 mL of blood
[27]. Thus, the multiplex nested PCR developed in the
current study was more sensitive. Cross-reactions with
other organisms aside from Candida as well as non-
specific amplifications in the control group were not ob-
served in the present study, indicating that this multiplex
nested PCR method is both specific and sensitive.
Our molecular assay yielded more positive results than
blood cultures (24.0% vs. 14.8%, respectively). Sequencing
of the amplification products obtained from the five PCR-
positive patients with negative blood cultures confirmed
that the amplification products were from the expected
Candida species, demonstrating the specificity of the test.
The statistical comparison between the two laboratory
techniques (blood culture versus multiplex nested PCR)
did not reveal a significant difference (p = 0.063), most
likely due to the restricted number of patients and sam-
ples (n = 54). Nevertheless, several studies have previ-
ously demonstrated that molecular techniques perform
better than culture methods [2,10,12].
In our study, C. albicans was the most frequently iso-
lated species in blood cultures (five out of eight positive
results), while the multiplex nested PCR identified C.
albicans, C. parapsilosis complex, and C. tropicalis at
similar frequencies (Table 2). Thus, the molecular tool
allowed the identification of a range of different Can-
dida species that cause bloodstream infections in these
critically ill paediatric patients.
Dual candidaemia was detected in three patients only by
the multiplex nested PCR method (C. parapsilosis sensu
stricto and C. tropicalis). In fact, dual candidaemia has been
increasingly reported with the advent of diagnostic molecu-
lar tools and may be clinically relevant in cases in which
one of the detected Candida species is resistant to drugs
usually employed in the antifungal therapy [11,12,28,29].
However, as reported in other studies [30,31], it was not
possible to differentiate the dual candidaemia patients from
those with only one Candida species with respect to the
risk factors and the infection outcome, probably because of
the restricted number of cases. Although C. albicans is
often involved in mixed candidaemia episodes [29-31], this
species was not present in these three particular cases. This
may be related to the fact that in Brazil C. parapsilosis and
C. tropicalis are the non-C. albicans species more fre-
quently isolated from candidaemia episodes, particularly in
paediatric ICU patients [32,33].
While detection of Candida DNA by the PCR assay in
blood samples from patients with negative cultures can be
related to transient episodes rather than true candidaemia,
the finding of a positive PCR in a critically ill patient
should be strongly considered due to the high potential of
this eventually transient episode to rapidly turn into a sys-
temic infection. On the other hand, the fact that our
multiplex PCR assay was negative in all 28 control chil-
dren, strongly suggests that this assay can be useful, in as-
sociation with appropriate clinical evaluation, to rule out
the presence of candidaemia and interrupt unnecessary
Table 2 Demographic, clinical, and laboratory data of the 13 patients with positive PCR
Patients G Age Underlying disease BSAT CVC AFT Outcome Blood cultures Nested PCR multiplex
1 M 19 d Ichthyosis, prematurity Yes Yes Yes Died C.parapsilosis C. parapsilosis
2 M 14 d Prematurity Yes Yes Yes Survived C. albicans C. albicans
3 F 44 d Esophageal atresia Yes Yes Yes Survived C. albicans C. albicans
4 F 20 m Acute lymphoblastic leukemia Yes Yes Yes Died C. tropicalis C. tropicalis
5 M 20 m Non-Hodgkin lymphoma Yes Yes Yes Survived C. albicans C. albicans
6 F 11 m Hydrocephalus Yes Yes Yes Survived C. albicans C. albicans
7 M 5 y Disseminated medullobastoma Yes Yes Yes Died C. krusei C. krusei
8 F 16 m Hydrocephalus Yes Yes Yes Died C. albicans C. albicans
9 M 3 y Bone marrow transplantation, neuroblastoma Yes Yes Yes Died Negative C. tropicalis and C. parapsilosisa
10 F 15 y Osteosarcoma, septic shock Yes Yes Yes Died Negative C. parapsilosisa
11 M 35 d Congenital diaphragmatic hernia Yes Yes Yes Survived Negative C. tropicalisa
12 M 9 d Congenital diaphragmatic hernia Yes Yes Yes Survived Negative C. tropicalis and C. parapsilosisa
13 M 55 d Necrotizing enterocholitis Yes Yes Yes Died Negative C. tropicalis and C. parapsilosisa
G = gender; M = male; F = female; d = days; m = months; y = years; BSAT = broad spectrum antibiotic therapy; CVC = central venous catheter;
AFT = presumptive antifungal therapy after blood sample collections.
a = Sequencing analysis showed 99-100% identity with C. parapsilosis stricto sensu [GenBank: JN997459.1] and 99-100% identity with C. tropicalis
[GenBank: EU266571.1].
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antifungal therapy [34]. Studies with higher number of pa-
tients are necessary to determine precisely its negative
predictive value.
Our multiplex nested PCR method showed other im-
portant advantages. The time to PCR results was 24 hours,
while the mean time to release blood culture results was
72 hours, ranging from 48 to 96 hours considering the pa-
tients in this study. The ability to detect infection early
and discriminate Candida species is extremely important
for planning the introduction of antifungal therapy, thus
improving the outcome of infected patients and reducing
the hospitalisation costs [11]. In addition this assay allows
for the detection of Candida in small volumes of blood,
which is an advantage for ICU neonates and younger chil-
dren [6]. However, this study was designed such that equal
volumes of blood were used to perform cultures and PCR
(1-2 mL) to ensure that the results were comparable.
An intrinsic limitation of studies designed to validate
molecular diagnostic tools for Candida infections is that
the gold standard method—blood culture—is a technique
that lacks sensitivity [2]. Other tests that could eventually
be used to confirm the molecular results, such as the β-1,3
glucan and mannan tests, also lack sensitivity and specifi-
city [35,36].
Novel technologies have recently been exploited for rapid
detection and identification of Candida species in blood-
stream infections. Some assays based on real- time plat-
forms have also been developed to detect candidaemia,
though some limitations of sensitivity and specificity were
observed [36,37]. A recently described magnetic resonance-
based technology (T2Candida®) seems to be able to detect
low concentrations of Candida in whole blood samples (as
low as one CFU/mL) in less than two hours [38]. However,
further investigations are still required for validation of
both methodologies in the clinical and laboratory settings.
We proposed a multiplex PCR assay targeting the ITS
region of Candida ribosomal DNA able to identify the
main Candida species involved in bloodstream paediatric
infections with a detection limit of less than 10 CFU/mL,
high specificity, and as least as sensitive as blood cultures
but with a shorter turnaround time. Use of the multiplex
nested PCR method also allowed the detection and identi-
fication of one or more Candida species in the same
reaction.
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